A Tick Vector Transmission Model of Monocytotropic Ehrlichiosis

Journal of Infectious Diseases

Volumn 212, Issue 6, 2015, Pages 968-977

  Saito, Tais Berelli ^a   Walker, David H ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

animal model; Ehrlichia muris like; ehrlichiosis; emerging infectious disease; human pathogen; tick; vector borne

Indexed keywords

BACTERIUM ANTIBODY; EHRLICHIAL ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; BACTERIAL LOAD; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BONE MARROW; BRAIN; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE TRANSMISSION; EHRLICHIA MURIS; EHRLICHIOSIS; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IXODES SCAPULARIS; KIDNEY; LETHALITY; LIVER; LUNG; LYMPH NODE; MOLTING; MONOCYTOTROPIC EHRLICHIOSIS; MOUSE; NONHUMAN; NYMPH; PRIORITY JOURNAL; SPLEEN; TICK BORNE DISEASE; TISSUE DISTRIBUTION; ANIMAL; C57BL MOUSE; CLASSIFICATION; COMMUNICABLE DISEASE; DISEASE MODEL; EHRLICHIA; IXODES; LARVA; MICROBIOLOGY; PARASITE VECTOR; PARASITOLOGY; PATHOLOGY; PHYSIOLOGY; TICK INFESTATION; TRANSMISSION;

ANIMALS; ARACHNID VECTORS; COMMUNICABLE DISEASES, EMERGING; DISEASE MODELS, ANIMAL; EHRLICHIA; EHRLICHIOSIS; FEMALE; IXODES; LARVA; MICE; MICE, INBRED C57BL; NYMPH; TICK INFESTATIONS; TICK-BORNE DISEASES;

EID: 84940760902     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv134     Document Type: Conference Paper

References (21)

1. Groves MG, Dennis GL, Amyx HL, Huxsoll DL. Transmission of Ehrlichia canis to dogs by ticks (Rhipicephalus sanguineus). Am J Vet Res 1975; 36:937-40.
2. Long SW, Zhang X, Zhang J, Ruble RP, Teel P, Yu XJ. Evaluation of transovarial transmission and transmissibility of Ehrlichia chaffeensis (Rickettsiales: Anaplasmataceae) in Amblyomma americanum (Acari: Ixodidae). J Med Entomol 2003; 40:1000-4.
3. Pretorius A, van Kleef M, Collins NE, et al. A heterologous prime/boost immunisation strategy protects against virulent E. ruminantium Welgevonden needle challenge but not against tick challenge. Vaccine 2008; 26:4363-71.
4. Fourie JJ, Stanneck D, Luus HG, Beugnet F, Wijnveld M, Jongejan F. Transmission of Ehrlichia canis by Rhipicephalus sanguineus ticks feeding on dogs and on artificial membranes. Vet Parasitol 2013; 197:595-603.
5. Harrus S, Waner T, Aizenberg I, Foley JE, Poland AM, Bark H. Amplification of ehrlichial DNA from dogs 34 months after infection with Ehrlichia canis. J Clin Microbiol 1998; 36:73-6.
6. Saito TB, Thirumalapura NR, Shelite TR, Rockx-Brouwer D, Popov VL, Walker DH. An animal model of a newly emerging human ehrlichiosis. J Infect Dis 2014; 211:452-61.
7. Kung F, Anguita J, Pal U. Borrelia burgdorferi and tick proteins supporting pathogen persistence in the vector. Future Microbiol 2013; 8:41-56.
8. Kern A, Collin E, Barthel C, Michel C, Jaulhac B, Boulanger N. Tick saliva represses innate immunity and cutaneous inflammation in a murine model of Lyme disease. Vector Borne Zoonotic Dis 2011; 11: 1343-50.
9. Mudenda L, Pierlé SA, Turse JE, et al. Proteomics informed by transcriptomics identifies novel secreted proteins in Dermacentor andersoni saliva. Int J Parasitol 2014; 44:1029-37.
10. Preston SG, Majtán J, Kouremenou C, et al. Novel immunomodulators from hard ticks selectively reprogramme human dendritic cell responses. PLOS Pathog 2013; 9:e1003450.
11. Wikel S. Ticks and tick-borne pathogens at the cutaneous interface: host defenses, tick countermeasures, and a suitable environment for pathogen establishment. Front Microbiol 2013; 4:337.
12. Sotomayor EA, Popov VL, Feng HM, Walker DH, Olano JP. Animal model of fatal human monocytotropic ehrlichiosis. Am J Pathol 2001; 158:757-69.
13. Lieskovská J, Kopecký J. Tick saliva suppresses IFN signalling in dendritic cells upon Borrelia afzelii infection. Parasite Immunol 2012; 34:32-9.
14. Oliveira CJ, Sá-Nunes A, Francischetti IM, et al. Deconstructing tick saliva: non-protein molecules with potent immunomodulatory properties. J Biol Chem 2011; 286:10960-9.
15. Alarcon-Chaidez FJ, Boppana VD, Hagymasi AT, Adler AJ, Wikel SK. A novel sphingomyelinase-like enzyme in Ixodes scapularis tick saliva drives host CD4 T cells to express IL-4. Parasite Immunol 2009; 31: 210-9.
16. Fourie JJ, Ollagnier C, Beugnet F, Luus HG, Jongejan F. Prevention of transmission of Ehrlichia canis by Rhipicephalus sanguineus ticks to dogs treated with a combination of fipronil, amitraz and (S)- methoprene (CERTIFECT®). Vet Parasitol 2013; 193:223-8.
17. Gaunt SD, Corstvet RE, Berry CM, Brennan B. Isolation of Ehrlichia canis from dogs following subcutaneous inoculation. J Clin Microbiol 1996; 34:1429-32.
18. Ferreira BR, Silva JS. Saliva of Rhipicephalus sanguineus tick impairs T cell proliferation and IFN-gamma-induced macrophage microbicidal activity. Vet Immunol Immunopathol 1998; 64:279-93.
19. Kazimírová M, Štibrániová I. Tick salivary compounds: their role in modulation of host defences and pathogen transmission. Front Cell Infect Microbiol 2013; 3:43.
20. Slovák M, Štibrániová I, Hajnická V, Nuttall PA. Antiplatelet-derived growth factor (PDGF) activity in the saliva of ixodid ticks is linked with their long mouthparts. Parasite Immunol 2014; 36:32-42.
21. Schuijt TJ, Bakhtiari K, Daffre S, et al. Factor Xa activation of factor V is of paramount importance in initiating the coagulation system: lessons from a tick salivary protein. Circulation 2013; 128:254-66.